TOPLINE: Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs), including liraglutide or semaglutide, for 12 months enabled patients to lose nearly all the weight they had regained after bariatric surgery. METHODOLOGY: Researchers conducted a single-centre retrospective study to examine the efficacy and safety of 12 months of treatment with GLP-1 RAs in patients who ...
Copyright © 2024 buzzstream. All Rights Reserved
Copyright © 2024 BuzzStream. All Rights Reserved.
All content on this website, including but not limited to text, images, graphics, logos, articles, and other materials, is the property of BuzzStream and is protected by international copyright laws. No part of this content may be reproduced, distributed, transmitted, displayed, published, or broadcast without BuzzStream's prior written permission. Unauthorized use of the content is strictly prohibited and may result in legal action.
For inquiries regarding the use or licensing of content, please contact us at 1-832-482-2215.
Feel free to customize it further if needed!